Inventor

Sarah Strong

Inventor
Louisville, CO, US

Overview

24→
Patents
2006–2017
Patent span
Human necessities
Primary field (CPC A)

Patents· 24 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds41%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
A61KPreparations for medical, dental or toiletry purposes19%
C07CAcyclic or carbocyclic compounds2%
PatentTitleYear
9,814,700'Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents'20179,498,466'Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents'20169,180,119'Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents'20159,145,410'Pyrazolopyridines and analogs thereof'20159,138,427'Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents'20159,029,402'Pyrrole inhibitors of S-nitrosoglutathione reductase'20158,957,105'Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents'20158,846,736'Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents'20148,716,320'Antibacteriall heterocyclic ureas'20148,697,720'Substituted phenylether-thienopyridone compounds with antibacterial activity'20148,691,816'Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents'20148,686,015'Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents'20148,673,961'Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents'20148,658,670'Methods and compounds for treatment of clostridium based infection'20148,642,628'Pyrrole inhibitors of S-nitrosoglutathione reductase'20148,470,857'Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents'20138,293,919'Antibacterial sulfone and sulfoxide substituted heterocyclic urea compounds'20128,148,380'Antibacterial amide and sulfonamide substituted heterocyclic urea compounds'20127,994,192'Substituted thienopyridone compounds with antibacterial activity'20117,973,050'Enantiomeric compounds with antibacterial activity'20117,879,849'Pyrazolopyridines and analogs thereof'20117,598,382'Aryl substituted imidazoquinolines'20097,544,697'Pyrazolopyridines and analogs thereof'20097,091,214'Aryl substituted Imidazoquinolines'2006

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2006–2009Based in Eagan, MN, US· patent location history
2009–2017Based in Louisville, CO, US· patent location history
2011–2014Patents assigned to CRESTONE INC (6)· patent assignee history
2012–2014Patents assigned to STRONG SARAH (9)· patent assignee history
2012–2014Patents assigned to SUN XICHENG (9)· patent assignee history
2012–2014Patents assigned to QIU JIAN (6)· patent assignee history
2013–2015Patents assigned to N30 PHARMACEUTICALS INC (10)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
N30 PHARMACEUTICALS INC102013–2015
STRONG SARAHself92012–2014
SUN XICHENG92012–2014
CRESTONE INC62011–2014
QIU JIAN62012–2014
Locations
LocationPatentsSpan
Louisville, CO, US222009–2017
Eagan, Minnesota, US22006–2009